Comprehensive Arthroscopic Management (CAM) Info Evidence Consent
Reviewed by Dr Kieran Hirpara, Specialist Orthopaedic Surgeon Last reviewed
Why this operation has been suggested
This page reflects how Dr Kieran Hirpara, an upper-limb surgeon at Mater Private Hospital Rockhampton, approaches this in our clinic. We recommend Comprehensive Arthroscopic Management (CAM) for early wear-and-tear arthritis of the shoulder. You typically reach our clinic by GP or physiotherapist referral. A clinic assessment establishes the diagnosis. For degenerative problems we usually try non-operative care first. We consider surgery when that has not given enough improvement.
CAM is a joint-preserving option for younger, active patients with advanced osteoarthritis. It is suitable if you have more than 2 mm of joint space and no significant deformity. The procedure aims to reduce pain and improve function. Evidence shows a 76.9% survivorship rate at a minimum of 5 years postoperatively. This means the joint remains intact without needing replacement in most cases. We present this as a shared decision based on your specific radiographic findings.
Before the operation
Please fast for six hours before your procedure. Stop specific blood thinners only after your surgeon advises. Arrange a lift home and bring a list of all current medications. Wear comfortable clothing. You may need X-rays, an MRI, or blood tests beforehand. These scans show joint wear, while blood tests check your general health. An anaesthetic review ensures you are safe for surgery. Your surgeon will guide you through these steps. This preparation helps us plan your care carefully. It also helps reduce risks during the operation. Please follow your surgeon’s specific instructions closely.
On the day
You will arrive at the hospital and check in with our nursing team. We will guide you to a pre-op room to get ready. Our anaesthetist will meet you there to discuss your care plan. This operation is done under general anaesthetic combined with a regional nerve block. You will be fully asleep for the operation, and the block — an injection that numbs the nerves supplying the arm before you wake up — provides pain relief for the first 12 to 24 hours after surgery. The anaesthetist will meet you before the operation and talk you through both parts.
Once you are settled, we will move you into the operating theatre. Our team will perform the procedure while you rest comfortably. When it is finished, we will take you to the recovery area to wake up safely. You will rest there while our staff monitor your comfort and vital signs. You may feel groggy at first, but the nerve block should keep pain manageable. We will check on you regularly until you are stable enough to return to your room or go home, depending on your recovery progress.
What the operation involves
Comprehensive Arthroscopic Management is a keyhole surgery designed to treat early wear-and-tear arthritis in your shoulder joint. We use small cameras and instruments inserted through tiny cuts in the skin, rather than one large incision. This approach allows us to see inside the joint clearly while keeping the trauma to your shoulder muscles and skin minimal.
During the procedure, we systematically address the specific issues causing your pain. We remove damaged tissue and smooth out rough edges on the bone surfaces. If there are loose fragments or inflamed tissue, we clean them away to improve movement. In some cases, we may resurface the socket of the shoulder joint to restore a smoother surface for the ball of the upper arm bone to glide against. We also release tight tissues that may be restricting your range of motion.
This approach is tailored to your specific anatomy. We assess whether you have enough joint space and if the bones are aligned correctly. If your joint space is less than 2 mm or if there is significant deformity, we may discuss other options, such as joint replacement, as these keyhole techniques may not be suitable. Similarly, if you have large bone spurs on the front of the shoulder, we might recommend a different procedure.
Once the work inside the joint is complete, we close the small cuts with stitches or glue and apply a dressing. The goal is to preserve your natural joint and delay the need for more invasive surgery. We aim to reduce your pain and improve your function, particularly if you are younger and active. This method offers a predictable short-term option for managing advanced arthritis without replacing the joint.
After the operation
You will wake up in the recovery ward. We manage your pain with general medication. Your shoulder stays in a sling and dressing for support. Keep the area clean and dry. Most patients stay one night in hospital after this operation, though some are able to go home the same day. You must have someone stay with you for the first 24 hours. Do not drive while in a sling or taking pain relief. You can drive once your surgeon clears you, typically at the six-week review. See our guide on Driving after upper-limb surgery for full details.
Recovery
You will notice swelling and stiffness in the days following your procedure. This is a normal part of the healing process. We manage this discomfort with prescribed medication and ice packs. Keep your arm elevated when resting to help reduce the swelling. Most patients find that the sharp pain fades into a dull ache within the first few weeks.
You will wear a sling to protect your shoulder while it heals. We guide you through gentle physiotherapy exercises to restore movement and strength. You must not drive while wearing the sling or if pain limits your reaction time. Our policy requires you to wait at least six weeks after any shoulder operation before driving, regardless of which arm was treated. You can drive again once your surgeon clears you, typically at the six-week review. For more details, see our guide on Driving after upper-limb surgery.
Daily activities change as you heal. You will need assistance with tasks like cooking or dressing initially. As your movement returns, you can gradually resume light household chores. Avoid heavy lifting or overhead reaching until your physiotherapist advises it is safe. Your timeline may differ; your surgeon and physio will guide you through each stage of recovery.
What can go wrong
Most patients do well, but problems can occasionally happen. Your surgeon and the team monitor you closely to spot any issue early.
If you have wear-and-tear arthritis in the shoulder joint, arthroscopic treatment usually helps you move better and feel less pain. Serious problems are rare. However, this approach is not always the right choice for everyone. It lacks strong proof that it works well for routine use in arthritis. If your pain does not improve, or if your movement stays stiff, this may be a sign that the procedure did not help as expected. You should discuss these ongoing symptoms with your surgeon at your next review to decide on the next steps.
If you are having arthroscopic stabilization to fix a loose joint, results can vary. Some people feel stable and pain-free, while others may still experience instability or discomfort. Because outcomes differ, it is important to pay attention to how your shoulder feels during recovery. If you notice a clicking, grinding, or slipping sensation when you move your arm, tell your surgeon. This feedback helps them understand if the stabilization is holding up or if further evaluation is needed.
For those with massive rotator cuff tears, arthroscopic debridement (cleaning out damaged tissue) may offer short-term relief. The long-term effects are not yet fully clear. If you find that your pain returns quickly, or if your strength does not improve over time, this could indicate that the cleaning did not provide lasting benefit. Keep a note of your daily function and share any setbacks with your care team so they can adjust your plan.
In very rare cases, a severe infection in the joint can lead to post-infectious arthritis. This means permanent damage to the joint surfaces after a serious infection. Signs include intense, deep pain that does not ease with simple painkillers, significant swelling, and redness spreading from the wound. If you suspect an infection, go to the emergency department or call your surgeon immediately. Early treatment is critical to prevent permanent joint damage.
The complications table on this page lists typical rates if you want the specifics.
When to call us
Call us if you have fever, increasing wound redness or discharge, or sudden severe pain. Go to emergency if you have calf swelling or shortness of breath. Call immediately for loss of sensation or inability to move your limb. Do not drive for at least six weeks after your operation. Contact us once your surgeon clears you, typically at the six-week review.
Evidence & references
Overview
- The Comprehensive Arthroscopic Management (CAM) procedure is a systematic, inclusive approach to the array of pathologies encountered in early glenohumeral arthritis [1].
- The CAM procedure provides a predictable short-term joint-preserving option for younger, high-demand patients with advanced glenohumeral osteoarthritis by reducing pain and improving function [2].
- The CAM procedure reduced pain, improved function, and provided reasonable short-term durability for young, active patients with advanced shoulder OA, serving as a joint-preserving alternative to arthroplasty [3].
- Arthroscopic debridement improved clinical outcome in 68% of patients suffering from advanced OA of the glenohumeral joint [5].
- The CAM procedure demonstrated significant improvements in midterm clinical outcomes and high patient satisfaction after the procedure for glenohumeral osteoarthritis, with a 76.9% survivorship rate at a minimum of 5 years postoperatively [6].
- Treatment of glenohumeral arthritis with arthroscopic glenoid resurfacing provided superior results compared to previously performed arthroscopic procedures in patients with failed previous arthroscopic debridement [7].
- CAM is a reasonable option for patients with localized cartilage defects and specific radiographic findings [10].
- Hemiarthroplasty (HA) or total shoulder arthroplasty (TSA) are feasible options for patients with humeral head incongruity or large anterior osteophytes [10].
- Arthroscopic debridement is an excellent treatment for elderly patients with modest functional demands, though long-term consequences require further evaluation [11].
- Isolated arthroscopic debridement and capsular release may not provide substantial benefit to justify its use in most patients with glenohumeral arthritis [12].
- Surgical arthroscopic repair was possible in all cases of acute or recurrent instability in soccer goalkeepers with well-defined exclusion criteria [14].
Anatomy & Pathophysiology
- The CAM procedure is a systematic, inclusive approach to the array of pathologies encountered in early glenohumeral arthritis [1].
- Advanced glenohumeral osteoarthritis is characterized by joint space loss and abnormal posterior glenoid shape [9].
- Humeral head flattening and severe joint incongruity are identified as risk factors for failure in patients undergoing arthroscopic treatment for glenohumeral osteoarthritis [22].
Classification
- Comprehensive Arthroscopic Management (CAM) is defined as a systematic, inclusive approach to the array of pathologies encountered in early glenohumeral arthritis [1].
- CAM provides a predictable short-term joint-preserving option for younger, high-demand patients with advanced glenohumeral osteoarthritis [2].
- CAM serves as a joint-preserving alternative to arthroplasty for young, active patients with advanced shoulder osteoarthritis [3].
- Arthroscopic debridement improved clinical outcomes in 68% of patients suffering from advanced osteoarthritis of the glenohumeral joint [5].
- CAM achieves significant improvements in midterm clinical outcomes and high patient satisfaction after the procedure for glenohumeral osteoarthritis [6].
- The survivorship rate of the arthroscopic CAM procedure is 76.9% at a minimum of 5 years postoperatively [6].
- Arthroscopic glenoid resurfacing provides superior results for the treatment of glenohumeral arthritis compared to previously performed arthroscopic procedures [7].
- An arthroscopic approach to glenohumeral arthritis using various joint-preserving procedures reduces pain, improves function, and improves clinical outcome scores in the short- to mid-term follow-up period [8].
- The CAM procedure reliably improves pain and function in active patients with advanced glenohumeral osteoarthritis [9].
- Patients with less joint space and abnormal posterior glenoid shape are significantly more likely to progress to early failure after the CAM procedure [9].
- CAM is a reasonable option for patients with localized cartilage defects and specific radiographic findings [10].
- Hemiarthroplasty or total shoulder arthroplasty are feasible options for patients with humeral head incongruity or large anterior osteophytes [10].
- Isolated arthroscopic debridement and capsular release may not provide substantial benefit to justify its use in most patients with glenohumeral arthritis [12].
- Arthroscopic debridement for glenohumeral arthritis lacks high-quality evidence to support its routine use [13].
- Surgical arthroscopic repair is possible for acute or recurrent instability with well-defined exclusion criteria [14].
- Comprehensive arthroscopic management without axillary nerve release or subacromial decompression achieves satisfactory and durable results in young patients with glenohumeral osteoarthritis [15].
Clinical Presentation
- Comprehensive Arthroscopic Management (CAM) is recommended for the array of pathologies encountered in early glenohumeral arthritis [1].
- CAM provides a predictable short-term joint-preserving option for younger, high-demand patients with advanced glenohumeral osteoarthritis [2].
- CAM serves as a joint-preserving alternative to arthroplasty for young, active patients with advanced shoulder osteoarthritis [3].
- Arthroscopic debridement improved clinical outcomes in 68% of patients suffering from advanced osteoarthritis of the glenohumeral joint [5].
- The CAM procedure demonstrates significant improvements in midterm clinical outcomes and high patient satisfaction for glenohumeral osteoarthritis [6].
- The CAM procedure has a 76.9% survivorship rate at a minimum of 5 years postoperatively [6].
- Arthroscopic glenoid resurfacing provided superior results compared to previously performed arthroscopic procedures for treating glenohumeral arthritis [7].
- An arthroscopic approach to glenohumeral arthritis using various joint-preserving procedures reduces pain, improves function, and improves clinical outcome scores in the short- to mid-term follow-up period [8].
- Patients with less joint space and abnormal posterior glenoid shape are significantly more likely to progress to early failure after the CAM procedure [9].
- CAM is a reasonable option for patients with localized cartilage defects and specific radiographic findings [10].
- Total shoulder arthroplasty (TSA) or hemiarthroplasty (HA) are feasible options for patients with humeral head incongruity or large anterior osteophytes [10].
- Arthroscopic debridement is an excellent treatment for elderly patients with modest functional demands [11].
- Isolated arthroscopic debridement and capsular release may not provide substantial benefit to justify its use in most patients with glenohumeral arthritis [12].
- Arthroscopic debridement for glenohumeral arthritis lacks high-quality evidence to support its routine use [13].
- Comprehensive arthroscopic management without axillary nerve release or subacromial decompression achieves satisfactory and durable results in young patients with glenohumeral osteoarthritis [15].
- Arthroscopic treatment of glenohumeral osteoarthritis provides improvements in range of motion and patient-reported outcomes with minimal complications [17].
- Arthroscopic debridement with capsular release may provide a window of improved symptoms and function before joint deterioration leads to more significant operations, especially in younger patients with mild or moderate osteoarthritic changes [19].
- Arthroscopic debridement and biological resurfacing of the glenoid is a minimally invasive therapeutic option for pain relief, functional improvement, and patient satisfaction in glenohumeral osteoarthritis in the intermediate-term [20].
Investigations
- The Comprehensive Arthroscopic Management (CAM) procedure is recommended as a systematic, inclusive approach to pathologies encountered in early glenohumeral arthritis [1].
- CAM provides a predictable short-term joint-preserving option for younger, high-demand patients with advanced glenohumeral osteoarthritis by reducing pain and improving function [2].
- The CAM procedure reduces pain, improves function, and provides reasonable short-term durability for young, active patients with advanced shoulder osteoarthritis, serving as a joint-preserving alternative to arthroplasty [3].
- Arthroscopic stabilization results are variable, requiring individual analysis of each technique to determine the role of arthroscopy in glenohumeral stabilization [4].
- Arthroscopic debridement improved clinical outcomes in 68% of patients suffering from advanced osteoarthritis of the glenohumeral joint [5].
- The CAM procedure demonstrates significant improvements in midterm clinical outcomes and high patient satisfaction, with a 76.9% survivorship rate at a minimum of 5 years postoperatively [6].
- Arthroscopic glenoid resurfacing provided superior results compared to previously performed arthroscopic procedures for the treatment of glenohumeral arthritis [7].
- An arthroscopic approach to glenohumeral arthritis using various joint-preserving procedures reduces pain, improves function, and improves clinical outcome scores in the short- to mid-term follow-up period [8].
- Patients with less joint space and abnormal posterior glenoid shape are significantly more likely to progress to early failure after the CAM procedure [9].
- CAM is a reasonable option for patients with localized cartilage defects and specific radiographic findings, while hemiarthroplasty (HA) or total shoulder arthroplasty (TSA) are feasible options for those with humeral head incongruity or large anterior osteophytes [10].
- Arthroscopic debridement is an excellent treatment for elderly patients with massive rotator cuff tears and modest functional demands, though long-term consequences require further evaluation [11].
- Surgical arthroscopic repair is possible for acute or recurrent instability in soccer goalkeepers with well-defined exclusion criteria [14].
- Comprehensive arthroscopic management without axillary nerve release or subacromial decompression achieves satisfactory and durable results in young patients with glenohumeral osteoarthritis [15].
- Arthroscopic debridement with capsular release may provide a window of improved symptoms and function before joint deterioration leads to more significant operations, especially in younger patients with mild or moderate osteoarthritic changes [19].
- Arthroscopic debridement, facetectomy, and synovectomy aim to decrease pain originating from the patellofemoral joint by eliminating pain sources from the subchondral bone and synovium [21].
- The survivorship rate of the CAM procedure at minimum 10-year follow-up is 63.2%, with humeral head flattening and severe joint incongruity identified as risk factors for failure [22].
- Progressive radiographic osteoarthritic changes following arthroscopic debridement of massive irreparable rotator cuff tears do not negatively influence clinical results [27].
Treatment
- Comprehensive Arthroscopic Management (CAM) is recommended as a systematic, inclusive approach for the array of pathologies encountered in early glenohumeral arthritis [1].
- CAM provides a predictable short-term joint-preserving option for younger, high-demand patients with advanced glenohumeral osteoarthritis by reducing pain and improving function [2].
- CAM reduces pain, improves function, and provides reasonable short-term durability for young, active patients with advanced shoulder osteoarthritis, serving as a joint-preserving alternative to arthroplasty [3].
- Arthroscopic stabilization results are variable, and each technique must be analyzed individually to determine the role of arthroscopy in glenohumeral stabilization [4].
- Arthroscopic debridement improved clinical outcomes in 68% of patients suffering from advanced osteoarthritis of the glenohumeral joint [5].
- The arthroscopic CAM procedure for glenohumeral osteoarthritis demonstrates significant improvements in midterm clinical outcomes and high patient satisfaction, with a 76.9% survivorship rate at a minimum of 5 years postoperatively [6].
- Arthroscopic glenoid resurfacing provided superior results for the treatment of glenohumeral arthritis compared to previously performed arthroscopic procedures in patients with failed prior debridement [7].
- An arthroscopic approach to glenohumeral arthritis using various joint-preserving procedures reduces pain, improves function, and improves clinical outcome scores in the short- to mid-term follow-up period [8].
- The CAM procedure reliably improves pain and function in active patients with advanced glenohumeral osteoarthritis, but patients with less joint space and abnormal posterior glenoid shape are significantly more likely to progress to early failure [9].
- CAM is a reasonable option for patients with primary glenohumeral arthritis younger than 50 years old who have localized cartilage defects and specific radiographic findings [10].
- Total shoulder arthroplasty or hemiarthroplasty are feasible options for patients with primary glenohumeral arthritis younger than 50 years old who have humeral head incongruity or large anterior osteophytes [10].
- Isolated arthroscopic debridement and capsular release may not provide substantial benefit to justify its use in most patients with glenohumeral arthritis [12].
- Arthroscopic debridement for glenohumeral arthritis lacks high-quality evidence to support its routine use [13].
- Comprehensive arthroscopic management without axillary nerve release or subacromial decompression achieves satisfactory and durable results in young patients with glenohumeral osteoarthritis [15].
- Arthroscopic debridement, facetectomy, and synovectomy aim to decrease pain originating from the patellofemoral joint by eliminating pain sources from the subchondral bone and synovium [21].
- Most perioperative costs associated with the arthroscopic treatment of glenohumeral instability are facility utilization and implant costs [26].
Complications
- Arthroscopic debridement for glenohumeral arthritis lacks high-quality evidence to support its routine use [13].
- Arthroscopic treatment of glenohumeral osteoarthritis provides improvements in ROM and patient-reported outcomes with minimal complications [17].
- The majority of patients demonstrated sustained improvement in patient-reported outcomes and satisfaction without conversion to total shoulder arthroplasty at long-term follow-up, although some patients progressed to arthroplasty [16].
- After the CAM procedure, 76.9% survivorship was observed at a minimum of 5 years postoperatively [6].
- After the CAM procedure, 84% survivorship was found at 3 years and 72% survivorship at 5 years [30].
Recovery
- The CAM procedure provides a predictable short-term joint-preserving option for younger, high-demand patients with advanced glenohumeral osteoarthritis by reducing pain and improving function [2].
- The CAM procedure reduced pain, improved function, and provided reasonable short-term durability for young, active patients with advanced shoulder OA [3].
- The CAM procedure serves as a joint-preserving alternative to arthroplasty for young, active patients with advanced shoulder OA [3].
- The CAM procedure reliably improves pain and function in active patients with advanced glenohumeral osteoarthritis (GHOA) [9].
- Patients with less joint space are significantly more likely to progress to early failure after the CAM procedure [9].
- Patients with abnormal posterior glenoid shape are significantly more likely to progress to early failure after the CAM procedure [9].
- The CAM procedure demonstrates significant improvements in midterm clinical outcomes and high patient satisfaction for GHOA [6].
- The CAM procedure has a 76.9% survivorship rate at a minimum of 5 years postoperatively [6].
- The majority of patients demonstrated sustained improvement in patient-reported outcomes and satisfaction without conversion to total shoulder arthroplasty at long-term follow-up after the CAM procedure [16].
- Some patients progressed to arthroplasty after the CAM procedure at long-term follow-up [16].
- Arthroscopic debridement improved clinical outcome in 68% of patients suffering from advanced OA of the glenohumeral joint [5].
- An arthroscopic approach to glenohumeral arthritis using various joint-preserving procedures reduces pain, improves function, and improves clinical outcome scores in the short- to mid-term follow-up period [8].
- Arthroscopic debridement is an excellent treatment for elderly patients with modest functional demands [11].
- Isolated arthroscopic debridement and capsular release may not provide substantial benefit to justify its use in most patients with glenohumeral arthritis [12].
- Arthroscopic debridement of the shoulder improves regaining external rotation in patients with osteoarthritis of the glenohumeral joint [18].
- Arthroscopic debridement of the shoulder decreases pain in patients with osteoarthritis of the glenohumeral joint [18].
- Arthroscopic debridement of the shoulder improves the ability to perform activities of daily living (ADLs) in patients with osteoarthritis of the glenohumeral joint [18].
- Arthroscopic debridement and biological resurfacing of the glenoid provides pain relief, functional improvement, and patient satisfaction in glenohumeral osteoarthritis in the intermediate-term [20].
Key Evidence
- [L4] The authors recommend a systematic, inclusive approach to the array of pathologies encountered in the setting of early glenohumeral arthritis: the Comprehensive Arthroscopic Management (CAM) procedure. [1] (10.1016/j.arthro.2022.01.033)
- [Paper] The comprehensive arthroscopic management procedure provides a predictable short-term joint-preserving option for younger, high-demand patients with advanced glenohumeral osteoarthritis by reducing pain and improving function. [2] (10.1016/j.eats.2015.04.003)
- [L4] The CAM procedure reduced pain, improved function, and provided reasonable short-term durability for young, active patients with advanced shoulder OA, serving as a joint-preserving alternative to arthroplasty. [3] (10.1016/j.arthro.2012.10.028)
- [L4] The results of arthroscopic stabilization reported in the literature are variable and each technique must be analyzed individually to properly determine the role of arthroscopy in glenohuminal stabilization. [4] (10.1177/03635465000280042801)
- [L3] Arthroscopic debridement improved clinical outcome in 68% of patients suffering from advanced OA of glenohumeral joint. [5] (10.1186/s12891-015-0741-9)
- [L4] This study demonstrates significant improvements in midterm clinical outcomes and high patient satisfaction after the arthroscopic CAM procedure for GHOA, with a 76.9% survivorship rate at a minimum of 5 years postoperatively. [6] (10.1177/0363546516656372)
- [L4] Treatment of glenohumeral arthritis with arthroscopic glenoid resurfacing provided superior results in this series to their previously performed arthroscopic procedure. [7] (10.1016/j.arthro.2009.04.015)
- [L5] Clinical studies report that an arthroscopic approach to glenohumeral arthritis using various joint-preserving procedures reduces pain, improves function, and improves clinical outcome scores in the short- to mid-term follow-up period. [8] (10.5435/jaaos-d-17-00214)
- [L3] The CAM procedure reliably improves pain and function in active patients with advanced GHOA, but patients with less joint space and abnormal posterior glenoid shape are significantly more likely to progress to early failure. [9] (10.1177/0363546516668823)
- [L4] CAM is a reasonable option for patients with localized cartilage defects and specific radiographic findings, while HA or TSA are feasible options for those with humeral head incongruity or large anterior osteophytes. [10] (10.1530/eor-2023-0156)
- [L3] Arthroscopic debridement is an excellent treatment for elderly patients with modest functional demands, though long-term consequences require further evaluation. [11] (10.1007/s00402-004-0738-6)
- [L4] Although there are limited nonarthroplasty surgical options available for glenohumeral arthritis, isolated arthroscopic debridement and capsular release may not provide substantial benefit to justify its use in most patients. [12] (10.1016/j.arthro.2014.08.025)
- [L1] This systematic review shows that arthroscopic debridement for glenohumeral arthritis lacks high-quality evidence to support its routine use. [13] (10.1016/j.arthro.2013.02.022)
- [L4] Surgical arthroscopic repair was possible in all cases of acute or recurrent instability with well-defined exclusion criteria. [14] (10.1055/s-0032-1327656)
- [L4] Comprehensive arthroscopic management without axillary nerve release or subacromial decompression achieves satisfactory and durable results in young patients with glenohumeral osteoarthritis. [15] (10.1007/s00167-023-07377-0)
- [L4] The majority of patients demonstrated sustained improvement in patient-reported outcomes and satisfaction without conversion to total shoulder arthroplasty at long-term follow-up, although some patients progressed to arthroplasty. [16] (10.1177/2325967121s00213)
- [L1] Arthroscopic treatment of glenohumeral osteoarthritis provides improvements in ROM and patient-reported outcomes with minimal complications. [17] (10.1016/j.arthro.2020.02.036)
- [L4] Arthroscopic debridement of the shoulder has a role to play in the management of osteoarthritis of the glenohumeral joint, with the most improvement in regaining external rotation, decreasing pain, and improvement in the ability to perform ADLs. [18] (10.1016/j.arthro.2010.04.032)
- [L4] Arthroscopic debridement with capsular release may provide a window of improved symptoms and function before deterioration of the joint leads to a more significant operation, especially in younger patients with mild or moderate osteoarthritic changes. [19] (10.1016/j.arthro.2006.11.016)
- [L4] Arthroscopic debridement and biological resurfacing of the glenoid is a minimally invasive therapeutic option for pain relief, functional improvement and patient satisfaction, in glenohumeral osteoarthritis, in the intermediate-term. [20] (10.1007/s00167-010-1155-8)
- [L4] The technique aims to decrease pain originating from the patellofemoral joint and related structures by eliminating pain sources from the subchondral bone and synovium. [21] (10.1016/j.eats.2021.08.021)
- [L3] The survivorship rate at minimum 10-year follow-up was 63.2%, with humeral head flattening and severe joint incongruity identified as risk factors for failure. [22] (10.1177/0363546520962756)
- [L4] Most perioperative costs associated with the arthroscopic treatment of glenohumeral instability are facility utilization and implant costs. [26] (10.1016/j.jseint.2020.01.006)
- [L4] Although progressive radiographic osteoarthritic changes occur, they do not negatively influence clinical results. [27] (10.1016/j.arthro.2008.03.007)
- [L4] After the CAM procedure we found an 84% survivorship at 3 years and 72% survivorship at 5 years. [30] (10.1177/2325967116s00104)
References
[1] Comprehensive Arthroscopic Management of Shoulder Arthritis. Arthroscopy. 2022. DOI: 10.1016/j.arthro.2022.01.033 [2] The Comprehensive Arthroscopic Management Procedure for Treatment of Glenohumeral Osteoarthritis. Arthroscopy Techniques. 2015. DOI: 10.1016/j.eats.2015.04.003 [3] Comprehensive Arthroscopic Management (CAM) Procedure: Clinical Results of a Joint‐Preserving Arthroscopic Treatment for Young, Active Patients With Advanced Shoulder Osteoarthritis. Arthroscopy. 2013. DOI: 10.1016/j.arthro.2012.10.028 [4] Arthroscopic Management of Glenohumeral Instability. The American Journal of Sports Medicine. 2000. DOI: 10.1177/03635465000280042801 [5] Relationship between probability of future shoulder arthroplasty and outcomes of arthroscopic debridement in patients with advanced osteoarthritis of glenohumeral joint. BMC Musculoskeletal Disorders. 2015. DOI: 10.1186/s12891-015-0741-9 [6] Survivorship and Patient-Reported Outcomes After Comprehensive Arthroscopic Management of Glenohumeral Osteoarthritis. The American Journal of Sports Medicine. 2016. DOI: 10.1177/0363546516656372 [7] Arthroscopic Glenoid Resurfacing: Results in Patients With Failed Previous Arthroscopic Debridement (SS‐14). Arthroscopy. 2009. DOI: 10.1016/j.arthro.2009.04.015 [8] Arthroscopic Management of Glenohumeral Arthritis: A Joint Preservation Approach. Journal of the American Academy of Orthopaedic Surgeons. 2018. DOI: 10.5435/jaaos-d-17-00214 [9] Comprehensive Arthroscopic Management of Glenohumeral Osteoarthritis: Preoperative Factors Predictive of Treatment Failure. The American Journal of Sports Medicine. 2016. DOI: 10.1177/0363546516668823 [10] Comprehensive arthroscopic management versus total shoulder arthroplasty and hemiarthroplasty in patients with primary glenohumeral arthritis younger than 50 years old. EFORT Open Reviews. 2026. DOI: 10.1530/eor-2023-0156 [11] Arthroscopic debridement of massive rotator cuff tears: negative prognostic factors. Archives of Orthopaedic and Trauma Surgery. 2004. DOI: 10.1007/s00402-004-0738-6 [12] Arthroscopic Debridement and Capsular Release for the Treatment of Shoulder Osteoarthritis. Arthroscopy. 2014. DOI: 10.1016/j.arthro.2014.08.025 [13] What Is the Role of Arthroscopic Debridement for Glenohumeral Arthritis? A Critical Examination of the Literature. Arthroscopy. 2013. DOI: 10.1016/j.arthro.2013.02.022 [14] Arthroscopic Treatment of Glenohumeral Instability in Soccer Goalkeepers. International Journal of Sports Medicine. 2012. DOI: 10.1055/s-0032-1327656 [15] Comprehensive arthroscopic management without axillary nerve release or subacromial decompression achieves satisfactory and durable results in young patients with glenohumeral osteoarthritis. Knee Surgery, Sports Traumatology, Arthroscopy. 2023. DOI: 10.1007/s00167-023-07377-0 [16] Survivorship and Patient-Reported Outcomes After Comprehensive Arthroscopic Management of Glenohumeral Osteoarthritis: Minimum 10-Year Follow-up. Orthopaedic Journal of Sports Medicine. 2021. DOI: 10.1177/2325967121s00213 [17] Outcomes and Survivorship After Arthroscopic Treatment of Glenohumeral Arthritis: A Systematic Review. Arthroscopy. 2020. DOI: 10.1016/j.arthro.2020.02.036 [18] Arthroscopic Debridement and Capsular release of the Shoulder as a Treatment for Osteoarthritis of the Glenohumeral Joint (SS‐22). Arthroscopy. 2010. DOI: 10.1016/j.arthro.2010.04.032 [19] Arthroscopic Debridement and Capsular Release for Glenohumeral Osteoarthritis. Arthroscopy. 2007. DOI: 10.1016/j.arthro.2006.11.016 [20] Arthroscopic debridement and biological resurfacing of the glenoid in glenohumeral arthritis. Knee Surgery, Sports Traumatology, Arthroscopy. 2010. DOI: 10.1007/s00167-010-1155-8 [21] Arthroscopic Debridement, Facetectomy, and Synovectomy for Isolated Patellofemoral Osteoarthritis. Arthroscopy Techniques. 2021. DOI: 10.1016/j.eats.2021.08.021 [22] Survivorship and Patient-Reported Outcomes After Comprehensive Arthroscopic Management of Glenohumeral Osteoarthritis: Minimum 10-Year Follow-up. The American Journal of Sports Medicine. 2020. DOI: 10.1177/0363546520962756 [26] A single-institution analysis of factors affecting costs in the arthroscopic treatment of glenohumeral instability. JSES International. 2020. DOI: 10.1016/j.jseint.2020.01.006 [27] Arthroscopic Debridement of Massive Irreparable Rotator Cuff Tears. Arthroscopy. 2008. DOI: 10.1016/j.arthro.2008.03.007 [30] Survivorship after Arthroscopic Management of Glenohumeral Osteoarthritis with a Minimum 5 year Follow-up. Orthopaedic Journal of Sports Medicine. 2016. DOI: 10.1177/2325967116s00104
